http://www.newstin.com/us/biotechnology Global Social News Platform Copyright © 2006 I2S a.s. Copyright © 2006 I2S a.s. http://www.newstin.com/tag/us/66369415 SUNRISE, Fla., July 3 /PRNewswire-FirstCall/ -- Bioheart, Inc., a biotechnology company that is focused on the development of autologous (patient-derived) cell therapies and devices for the treatment of chronic and acute heart... Thu, 03 Jul 2008 20:00:41 GMT http://www.newstin.com/tag/us/66369415 2008-07-03T20:00:41Z http://www.newstin.com/tag/us/66259485 Senesco Technologies, Inc. announced today that it has contracted with Polyplus-transfection to supply Polyplus's "in vivo-jetPEI" for systemic delivery of Senesco's combination therapy of siRNA against Factor 5A and a plasmid... Thu, 03 Jul 2008 12:29:38 GMT http://www.newstin.com/tag/us/66259485 2008-07-03T12:29:38Z http://www.newstin.com/tag/us/66273643 One of the great promises of embryonic stem cell research is being able to use human cloning to derive stem cells that carry genetic defects associated with myriad maladies, writes columnist Steve Clark, who explains recent... Thu, 03 Jul 2008 13:42:44 GMT http://www.newstin.com/tag/us/66273643 2008-07-03T13:42:44Z http://www.newstin.com/tag/us/66289070 Cardiff, UK, 31 January 2008 – Q Chip Ltd, a leading developer of microencapsulation solutions, today announced the appointment of Ken Powell as Executive Chairman. With a career spanning more than three decades as a senior... Thu, 03 Jul 2008 14:56:00 GMT http://www.newstin.com/tag/us/66289070 2008-07-03T14:56:00Z http://www.newstin.com/tag/us/66257036 NEW YORK (AP) - Shire Pharmaceuticals said Thursday it will buy German biotech company Jerini AG for 328 million euros ($521.2 million) in a move to expand its genetics portfolio. Jerini makes Firazyr, an orphan drug treatment... Thu, 03 Jul 2008 11:51:50 GMT http://www.newstin.com/tag/us/66257036 2008-07-03T11:51:50Z http://www.newstin.com/tag/us/66207968 According to recently released national rankings Colorado is a fertile state for bioscience and technology initiatives and were incredibly thrilled says Chris Shapard Deputy Director of the Colorado Bioscience Association CBSA... Thu, 03 Jul 2008 07:45:44 GMT http://www.newstin.com/tag/us/66207968 2008-07-03T07:45:44Z http://www.newstin.com/tag/us/66196559 Posted on: Thursday, 3 July 2008, 00:00 CDT LOS ANGELES, July 2 /PRNewswire/ -- Vista Partners announced today that it has updated coverage on leading Australian biotechnology company Arana Therapeutics, (ASX: AAH; AIM: AAHx).... Thu, 03 Jul 2008 05:00:27 GMT http://www.newstin.com/tag/us/66196559 2008-07-03T05:00:27Z http://www.newstin.com/tag/us/66201996 MiddleBrook CEO steps down, Equity Group investment aims to bring drug to market After eight years of struggling to make a success out of MiddleBrook Pharmaceuticals, chief executive and founder Edward M. Rudnic agreed to step... Thu, 03 Jul 2008 04:00:00 GMT http://www.newstin.com/tag/us/66201996 2008-07-03T04:00:00Z http://www.newstin.com/tag/us/66063257 Bioheart, Inc. a biotechnology company that is focused on the development of autologous cell therapies and devices for the treatment of chronic and acute heart damage, today announced it has been added to the Russell Microcap... Wed, 02 Jul 2008 15:47:54 GMT http://www.newstin.com/tag/us/66063257 2008-07-02T15:47:54Z http://www.newstin.com/tag/us/66104832 Kane Biotech Inc. (TSX VENTURE: KNE), a biotechnology company engaged in the development of products that prevent and remove microbial biofilms, is pleased to announce a research publication on its DispersinB(TM) technology. Wed, 02 Jul 2008 17:01:11 GMT http://www.newstin.com/tag/us/66104832 2008-07-02T17:01:11Z